Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct 15:4:29.
doi: 10.1186/s41256-019-0121-3. eCollection 2019.

A tool for estimating antiretroviral medication coverage for HIV-infected women during pregnancy (PMTCT-ACT)

Affiliations

A tool for estimating antiretroviral medication coverage for HIV-infected women during pregnancy (PMTCT-ACT)

Bruce A Larson et al. Glob Health Res Policy. .

Abstract

Background: In the typical prevention of mother to child transmission (PMTCT) of HIV cascade of care discussion or analysis, the period of analysis begins at the first visit for antenatal care (ANC) for that pregnancy. This starting point is problematic for two reasons: (1) a large number of HIV-infected women are already on life-long antiretroviral therapy (ART) when presenting for ANC; and (2) women present to ANC at different gestational ages. The PMTCT ART Coverage Tool (PMTCT-ACT), which estimates the proportion of days covered (PDC) with ART, was developed to address each of these problems.

Methods: PDC is a preferred method to measure adherence to chronic medications, such as ART. For evaluating the PMTCT cascade of care, as indicated by PDC with ART over various time periods, a "starting point" based on a specific day before delivery must be defined that applies to all women (treatment experienced or naïve at the first ANC visit at any gestational age). Using the example of 168 days prior to delivery (24 weeks), PMTCT-ACT measures PDC with ART during that period. PMTCT-ACT is provided as a STATA do-file. Using an example dataset for two women (ID1 is treatment experienced; ID2 is treatment naïve), the details of each major portion of the tool (Parts 1-5) are presented. PMTCT-ACT along with the intermediate datasets created during the analysis are provided as supplemental files.

Conclusions: Evaluating the PMTCT cascade of care requires a standard definition of the follow-up period during pregnancy that applies to all HIV-infected pregnant women and a standard measure of adherence. PMTCT-ACT is a new tool that fits this purpose. PMTCT-ACT can also be easily adjusted to evaluate other ante- and post-natal periods (e.g., final 4 weeks, final 8 weeks, complete pregnancy period, initial 24 weeks postpartum, time periods consistent with infant HIV testing guidelines).

Keywords: Cascade of care; Coverage; HIV; Pill count; Pregnancy; Prevention of mother-to-child transmission; Proportion of days covered.

PubMed Disclaimer

Conflict of interest statement

Competing interestsThe authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Reconceiving the PMTCT Cascade of Care for women in the antenatal period

Similar articles

Cited by

References

    1. WHO (World Health Organization). World health statistics 2017: monitoring health for the SDGs, Sustainable Development Goals. Geneva, Switzerland. Licence: CC BY-NC-SA 3.0 IGO.; 2017.
    1. WHO (World Health Organization). Prevention of mother-to-child transmission (PMTCT) Situation and trends. 2019.
    1. Vrazo AC, Firth J, Amzel A, Sedillo R, Ryan J, Phelps BR. Interventions to significantly improve service uptake and retention of HIV-positive pregnant women and HIV-exposed infants along the prevention of mother-to-child transmission continuum of care: systematic review. Trop Med Int Heal. 2018;23(2):136–148. doi: 10.1111/tmi.13014. - DOI - PubMed
    1. WHO (World Health Organization). Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations – 2016 Update. Geneva, Switzerland; 2016. - PubMed
    1. Rosala-Hallas A, Bartlett JW, Filteau S. Growth of HIV-exposed uninfected, compared with HIV-unexposed, Zambian children: a longitudinal analysis from infancy to school age. BMC Pediatr. 2017;17(1):80. doi: 10.1186/s12887-017-0828-6. - DOI - PMC - PubMed